Company news

Immatics N.V. news in 2020

Immatics N.V.'s news releases, calls and decks from 2020, newest first.

View company

Immatics Announces Third Quarter 2020 Financial Results and Business Update

December 1, 2020

Immatics Presents Phase I Data from ACTolog® Multi-Target Pilot Study IMA101 at the 35th Annual SITC Conference

November 9, 2020

Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA401 Targeting MAGEA4/8

October 28, 2020

Immatics Appoints Arnd Christ as Chief Financial Officer

September 28, 2020

Immatics Appoints Biotech Executive Eliot Forster to Board of Directors

September 14, 2020

Immatics Provides Update on IMA204 ACTengine® Cell Therapy Program Targeting the Tumor Microenvironment

September 9, 2020

Immatics Announces Second Quarter 2020 Financial Results and Business Update

September 2, 2020

Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs

August 17, 2020

Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth

August 5, 2020

Immatics Announces Board of Directors Additions Following Public Listing on NASDAQ

July 8, 2020

Immatics Announces Completion of Business Combination and Listing on NASDAQ

July 1, 2020

Decks in 2020